These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Levine GN; Ali MN Chest; 1997 Sep; 112(3):805-21. PubMed ID: 9315818 [No Abstract] [Full Text] [Related]
5. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Heusch G; Musiolik J; Kottenberg E; Peters J; Jakob H; Thielmann M Circ Res; 2012 Jan; 110(1):111-5. PubMed ID: 22116817 [TBL] [Abstract][Full Text] [Related]
6. Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy. Kato T; Yoshimoto N Drugs; 2003; 63(2):133-8. PubMed ID: 12515561 [TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications]. Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017 [TBL] [Abstract][Full Text] [Related]
10. [Myocardial ischemic preconditioning: pathophysiological mechanisms and prospects of clinical application (a literature review)]. Petrishchev NN; Shliakhto EV; Vlasov TD; Galagudza MM Ross Fiziol Zh Im I M Sechenova; 2001 May; 87(5):688-705. PubMed ID: 11452804 [TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of preconditioning and implications for the cardiac surgeon. Kloner RA; Przyklenk K; Shook T; Matthews RV; Burstein S; Cannom DS; Isber N; Kay G J Card Surg; 1995 Jul; 10(4 Suppl):369-75. PubMed ID: 7579829 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioning. Napoli C; Pinto A; Cirino G Pharmacol Ther; 2000 Dec; 88(3):311-31. PubMed ID: 11337029 [TBL] [Abstract][Full Text] [Related]
13. Does ischemic preconditioning occur in patients? Kloner RA; Yellon D J Am Coll Cardiol; 1994 Oct; 24(4):1133-42. PubMed ID: 7930208 [TBL] [Abstract][Full Text] [Related]
14. Toward the heart of ischemic preconditioning. Dekker LR Cardiovasc Res; 1998 Jan; 37(1):14-20. PubMed ID: 9539853 [No Abstract] [Full Text] [Related]
15. [Opinions on the cardioprotective influence of ischemic preconditioning]. Negrusz-Kawecka M; Mazurek W Pol Arch Med Wewn; 1999 Jan; 101(1):75-80. PubMed ID: 10592733 [No Abstract] [Full Text] [Related]
16. Revascularization procedures in the treatment of single-vessel coronary disease. Parisi AF; Burtt DM Coron Artery Dis; 1993 Dec; 4(12):1053-60. PubMed ID: 7909263 [No Abstract] [Full Text] [Related]
18. [Induction of increased cardiac tolerance against damage--a new therapeutic principle?]. Ilebekk A; Grand F Tidsskr Nor Laegeforen; 1997 Jun; 117(16):2333-4. PubMed ID: 9265279 [TBL] [Abstract][Full Text] [Related]